chr7-147308952-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.1498+8662A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.525 in 152,046 control chromosomes in the GnomAD database, including 21,813 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.53 ( 21813 hom., cov: 32)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.397

Publications

1 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.71 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014141.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
NM_014141.6
MANE Select
c.1498+8662A>G
intron
N/ANP_054860.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
ENST00000361727.8
TSL:1 MANE Select
c.1498+8662A>G
intron
N/AENSP00000354778.3
CNTNAP2
ENST00000636870.1
TSL:5
n.1360+8662A>G
intron
N/A
CNTNAP2
ENST00000637694.1
TSL:5
n.1401+8662A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.525
AC:
79791
AN:
151928
Hom.:
21778
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.657
Gnomad AMI
AF:
0.578
Gnomad AMR
AF:
0.539
Gnomad ASJ
AF:
0.503
Gnomad EAS
AF:
0.730
Gnomad SAS
AF:
0.593
Gnomad FIN
AF:
0.367
Gnomad MID
AF:
0.497
Gnomad NFE
AF:
0.448
Gnomad OTH
AF:
0.500
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.525
AC:
79878
AN:
152046
Hom.:
21813
Cov.:
32
AF XY:
0.525
AC XY:
39033
AN XY:
74292
show subpopulations
African (AFR)
AF:
0.657
AC:
27253
AN:
41482
American (AMR)
AF:
0.539
AC:
8231
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.503
AC:
1745
AN:
3470
East Asian (EAS)
AF:
0.730
AC:
3772
AN:
5168
South Asian (SAS)
AF:
0.593
AC:
2855
AN:
4812
European-Finnish (FIN)
AF:
0.367
AC:
3876
AN:
10566
Middle Eastern (MID)
AF:
0.507
AC:
148
AN:
292
European-Non Finnish (NFE)
AF:
0.448
AC:
30420
AN:
67964
Other (OTH)
AF:
0.498
AC:
1051
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1904
3808
5712
7616
9520
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
708
1416
2124
2832
3540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.476
Hom.:
9205
Bravo
AF:
0.543
Asia WGS
AF:
0.624
AC:
2167
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
1.7
DANN
Benign
0.74
PhyloP100
-0.40
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2692179; hg19: chr7-147006044; API